Arthritis, Musculoskeletal And Skin Diseases Research in FY2025

Arthritis, Musculoskeletal And Skin Diseases Research overlapping FY2025 — CFDA 93.846

Two tables meet. One table is CFDA 93.846 (Arthritis, Musculoskeletal And Skin Diseases Research). The other is fiscal year 2025. $576,388,885.74 is the obligation aggregate for rows that carry both keys on the yearlyTrend table. The FY2025 cell is 13.4% of the program-wide $4,315,511,081.33 book on 2,683 awards. The remaining catalog dollars sit on other fiscal-year rows this page does not reprint. This page is that program–year join, not a patient census, a clinic directory, a named-investigator roster, or a disease ranking. The join does not prove that fiscal year 2025 caused Arthritis, Musculoskeletal And Skin Diseases Research activity, only that USAspending coded the two keys together. FEC donation tables do not fund these USAspending obligations.

SpendingVault indexes the cell from USAspending.gov. The catalog title on the program side is ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH. The year on the other side is federal fiscal year 2025. Neither label is a contractor, a place of performance, or an awarding-agency code — this packet publishes no awarding agency and no named recipients. Parent without the year: /programs/93.846/ (CFDA 93.846). Parent without the CFDA: /fiscal-years/2025/ (FY2025 federal spending). 561 FY2025 awards make this a research-award file, still not a count of laboratories or investigators. Outlays are not this field.

What CFDA 93.846 contributes to the FY2025 cell

CFDA 93.846 is the Catalog of Federal Domestic Assistance identifier for Arthritis, Musculoskeletal And Skin Diseases Research. The official title is ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH. The program-wide obligation total in this extract is $4,315,511,081.33 across 2,683 awards. That figure is a program rollup, not a second headline for the FY2025 cell unless the two amounts match. Do not treat $4,315,511,081.33 as cash Treasury already sent. SpendingVault does not grade program performance. Do not mix allergy research (93.855) or cancer detection research (93.394) into this 93.846 cell. Mixing those other keys into $576,388,885.74 would invent a combined total the packet never computed.

Open CFDA 93.846 at /programs/93.846/ for the program hub. That page is not this join: it can include other fiscal years if the extract lists them, and it is still obligations rather than outlays. This ties page stays on CFDA 93.846 in FY2025 only. Campaign-finance filings do not fund these USAspending obligations. Unique recipients remain unpublished. Later bulk files can move both the dollars and the 561-award count without changing the join keys.

FY2025 inside a larger federal-year index

Federal fiscal year 2025 is the time key on this yearlyTrend row. The year hub FY2025 federal spending at /fiscal-years/2025/ rolls up every program that year in the index, not only Arthritis, Musculoskeletal And Skin Diseases Research. Reading $576,388,885.74 as all FY2025 federal obligations would over-read this cell. The join is one CFDA inside one fiscal year, not a Budget Appendix score and not a Treasury cash statement. Agency splits, place-of-performance maps, and recipient UEIs are omitted from this packet.

561 FY2025 awards are not a count of laboratories or investigators

The extract lists 561 awards on the Arthritis, Musculoskeletal And Skin Diseases Research × FY2025 table. That is an award-record count for this yearlyTrend cell, not a count of laboratories or investigators. Unique recipients are unpublished. Continuations and modifications can add lines without naming a new organization. Dividing $576,388,885.74 by 561 is not published here as a typical award size, because the packet does not say the rows are comparable. The program-wide award count is 2,683, a different denominator.

Unit rankings this Arthritis, Musculoskeletal And Skin Diseases Research–FY2025 join cannot support

An obligation is a legal commitment. An outlay is a payment. $576,388,885.74 is the former. Citing it as cash already cleared on Arthritis, Musculoskeletal And Skin Diseases Research in FY2025 over-reads the field. Keep $576,388,885.74 labeled as Arthritis, Musculoskeletal And Skin Diseases Research obligations in fiscal year 2025. No named contractors or labs or investigators appear here. Quote Arthritis, Musculoskeletal And Skin Diseases Research and FY2025 with $576,388,885.74. Keep CFDA 93.846 in the citation.

Budget justifications and press releases are not the source of this cell. If a chart mixes a different CFDA with FY2025 or a different fiscal year with Arthritis, Musculoskeletal And Skin Diseases Research, the chart has left this join. Do not mix allergy research (93.855) or cancer detection research (93.394) into this 93.846 cell. Correlation with news headlines is not causation.

Internal links around Arthritis, Musculoskeletal And Skin Diseases Research and FY2025

Open /programs/93.846/ for CFDA 93.846, /fiscal-years/2025/ for FY2025 federal spending, /programs/ for All programs, and /ties/ for All spending ties. Those parents are larger than this cell. Keep both join sides on the same line as $576,388,885.74. USAspending.gov remains the source. A ties page exists because two tables meet. One table is CFDA 93.846. The other is fiscal year 2025. $576,388,885.74 is the obligation sum on that intersection, not a forecast and not a claim that Arthritis, Musculoskeletal And Skin Diseases Research caused any outcome statistic to move.

Step off this pair through the internal links. Keep Arthritis, Musculoskeletal And Skin Diseases Research and FY2025 together when citing $576,388,885.74. CFDA 93.846's program-wide award-record count is 2,683, not a FY2025-only census of labs or investigators. Obligations of $576,388,885.74 are not outlays. Original filings remain on USAspending.gov for this 93.846 × FY2025 pair. Campaign-finance tables do not fund these USAspending obligations. Unique recipients remain unpublished. Quote CFDA 93.846, fiscal year 2025, and $576,388,885.74 in one sentence.

Questions

How much did Arthritis, Musculoskeletal And Skin Diseases Research obligate in FY2025?

USAspending.gov records $576,388,885.74 in CFDA 93.846 obligations tagged to fiscal year 2025 across 561 awards. That cell is 13.4% of the program-wide $4,315,511,081.33 book, not an outlay. The pair is Arthritis, Musculoskeletal And Skin Diseases Research plus FY2025.

Does the FY2025 award count identify unique labs or investigators?

No. 561 is an FY2025 award-record count on a research-award file. The program-wide extract lists 2,683 awards. Recipients are unpublished. The count is not a count of laboratories or investigators. USAspending.gov remains the source for this pair. Unique recipients remain unpublished on this 93.846 × FY2025 join.

Can $576,388,885.74 be cited as Treasury payments?

No. $576,388,885.74 is an obligation aggregate. Outlays are unpublished. Payments from the Treasury can lag or differ. FEC donations do not fund this USAspending cell. Original filings remain on USAspending.gov. The program-wide book is $4,315,511,081.33 on 2,683 awards, a different rollup.

Which pages parent Arthritis, Musculoskeletal And Skin Diseases Research and FY2025?

/programs/93.846/ is the program parent. /fiscal-years/2025/ is the FY2025 parent. /programs/ lists programs. /ties/ lists other pairs. Prefer those tables after later ingests; this page quotes Arthritis, Musculoskeletal And Skin Diseases Research × FY2025 at $576,388,885.74. Keep CFDA 93.846 in the citation alongside fiscal year 2025.